Researchers are exploring the use of artificial chromosomes for disease modeling, with advancements in synthetic rewriting technologies and genome editing enabling the creation of humanized mouse models. These models may be used to study various diseases, including Parkinson's disease and cancer, although the effectiveness of preclinical models is being questioned. The development of these models involves techniques such as mouse artificial chromosome integration and triple BAC integration, with potential applications in drug discovery and development.